Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Saliba, Antoine N
352  Ergebnisse:
Personensuche X
?
1

A phase I study of pevonedistat, azacitidine, and venetocla..:

Murthy, Guru Subramanian Guru ; Saliba, Antoine N. ; Szabo, Aniko...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
2

FLT3 inhibitors potentially improve response rates in acute..:

Csizmar, Clifford M. ; Saliba, Antoine N. ; Greipp, Patricia T....
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
3

Cladribine plus cytarabine plus venetoclax in acute myeloid..:

Steinauer, Nickolas ; McCullough, Kristen ; Al-Kali, Aref...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
4

Comparing venetoclax in combination with hypomethylating ag..:

Badar, Talha ; Nanaa, Ahmad ; Atallah, Ehab...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
5

Prognostic impact of 'multi-hit' versus 'single hit' TP53 a..:

Badar, Talha ; Nanaa, Ahmad ; Atallah, Ehab...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
6

Cardiac events in newly diagnosed acute myeloid leukaemia d..:

Johnson, Isla M. ; Karrar, Omer ; Rana, Masooma...
British Journal of Haematology.  204 (2024)  4 - p. 1232-1237 , 2024
Link: https://doi.org/10.1111/..
 
?
7

AMPK inhibition sensitizes acute leukemia cells to BH3 mime..:

Jia, Jia ; Ji, Wenbo ; Saliba, Antoine N....
Cell Death & Differentiation.  31 (2024)  4 - p. 405-416 , 2024
Link: https://doi.org/10.1038/..
 
?
8

Hematological manifestations of antiphospholipid syndrome: ..:

El Hasbani, Georges ; Saliba, Antoine N. ; Uthman, Imad.
Blood Reviews.  58 (2023)  - p. 101015 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Venetoclax and hypomethylating agent combination therapy in..:

Gangat, Naseema ; Karrar, Omer ; Iftikhar, Moazah...
American Journal of Hematology.  99 (2023)  2 - p. 193-202 , 2023
Link: https://doi.org/10.1002/..
 
?
10

Survival of TP53-mutated acute myeloid leukemia patients re..:

Badar, Talha ; Atallah, Ehab ; Shallis, Rory...
Leukemia.  37 (2023)  4 - p. 799-806 , 2023
Link: https://doi.org/10.1038/..
 
?
11

Pevonedistat with azacitidine in older patients with TP53-m..:

Saliba, Antoine N. ; Kaufmann, Scott H. ; Stein, Eytan M....
Blood Advances.  7 (2023)  11 - p. 2360-2363 , 2023
Link: https://doi.org/10.1182/..
 
?
12

Minimal residual disease in Philadelphia‐positive acute lym..:

Saliba, Antoine N. ; Foà, Robin
American Journal of Hematology.  98 (2023)  8 - p. 1168-1170 , 2023
Link: https://doi.org/10.1002/..
 
?
13

Disparities in receiving disease‐directed therapy, allogene..:

Badar, Talha ; Litzow, Mark R. ; Shallis, Rory M....
Cancer.  129 (2022)  6 - p. 934-945 , 2022
Link: https://doi.org/10.1002/..
 
?
14

Outcomes of TP53‐mutated AML with evolving frontline therap..:

Badar, Talha ; Atallah, Ehab ; Shallis, Rory M....
American Journal of Hematology.  97 (2022)  7 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
15

The evolution of frontline therapy for adult Philadelphia‐p..:

Saliba, Antoine N. ; Foà, Robin
American Journal of Hematology.  98 (2022)  3 - p. 374-376 , 2022
Link: https://doi.org/10.1002/..
 
1-15